APA (7th ed.) Citation

Patrizia Murer, Barbara Brannetti, Jean-Michel Rondeau, Laetitia Petersen, Nicole Egli, Simone Popp, . . . Christoph Huber. (2024). Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Patrizia Murer, et al. Discovery and Development of ANV419, an IL-2/anti-IL-2 Antibody Fusion Protein with Potent CD8+ T and Natural Killer Cell-stimulating Capacity for Cancer Immunotherapy. Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Patrizia Murer, et al. Discovery and Development of ANV419, an IL-2/anti-IL-2 Antibody Fusion Protein with Potent CD8+ T and Natural Killer Cell-stimulating Capacity for Cancer Immunotherapy. Taylor & Francis Group, 2024.